Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

DSDs are birth conditions causing unusual sex development, managed with personalized care and sometimes surgery, but still lack a standard treatment approach.

ADSC therapy is more effective and safer for treating photoaged skin than PRP.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Dextroamphetamine may help treat alopecia areata.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Biomimetic dermal papilla spheres can help regenerate hair to some extent.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Genomic prediction can improve breeding strategies for Korean Sapsaree dogs.

Pantothenic acid helps mink hair follicles grow by affecting certain cell signals.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Genetically modifying a bacteria and changing its growth conditions significantly increased the production of a chemical called dipicolinic acid.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

PGD2 stops hair growth and is higher in bald men with AGA.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

A new DSG4 gene mutation causes hair defects in a young girl.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Biopsy is crucial for accurately diagnosing EPDS to avoid mistaking it for SCC.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

GD-23 reduces anxiety by relying on neurosteroid production.